Dual-Task Training for Parkinson's (NCT07536542)
Multitasking exercises improve arm strength
- Trial ID
- NCT07536542
- Official Title
- Effects of Dual-Task Training on Upper Extremity Function and Muscle Thickness in Parkinson's Disease
- Goal
- Multitasking exercises improve arm strength
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Ankara University
- Study Type
- INTERVENTIONAL
- Enrollment
- 38 participants
- Conditions
- Parkinson Disease (PD)
- Interventions
- Dual-Task Training
Summary For Families
The goal is to improve arm and hand function and increase muscle thickness in people with Parkinson's by reducing the drop in performance that happens when you try to move while also doing a thinking task. The approach is dual-task training, where repetitive upper-limb exercises are practiced at the same time as a cognitive or secondary motor task to retrain attention, timing, muscle activation, and strength; it is a non-drug rehabilitation method and does not directly interact with levodopa, and participants must have had no medication changes in the past 6 months. Participants should be aged 40 to 65 with idiopathic Parkinson's at Hoehn and Yahr stage 2 to 3, able to follow instructions (MoCA ≥21), and free of major upper limb injuries, atypical parkinsonism, severe sensory or psychiatric problems that would prevent regular participation.
Locations
- Hacettepe University, Ankara, Turkey (Türkiye)
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Dual-Task Training. The goal is to improve arm and hand function and increase muscle thickness in people with Parkinson's by reducing the drop in performance that happens when you try to move while also doing a thinking task. The approach is dual-task training, where repetitive upper-limb exercises are practiced at the same time as a cognitive or secondary motor task to retrain attention, timing, muscle activation, and strength; it is a non-drug rehabilitation method and does not directly interact with levodopa, and participants must have had no medication changes in the past 6 months. Participants should be aged 40 to 65 with idiopathic Parkinson's at Hoehn and Yahr stage 2 to 3, able to follow instructions (MoCA ≥21), and free of major upper limb injuries, atypical parkinsonism, severe sensory or psychiatric problems that would prevent regular participation.
- Who can participate?
- Participants must be between 40 Years and 65 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 3 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This trial has a group that receives no study treatment (you would continue your usual care) alongside the treatment group. Because assignment is random, you have about a 1 in 2 chance (roughly 50%) of being in the no-treatment group, assuming the groups are filled equally. Ask the coordinator to confirm the exact assignment ratio.
- How many visits does this trial involve?
- Participants will complete baseline and post-intervention assessments, and those in the intervention group will receive training 3 times per week for 8 weeks with each session lasting 60 minutes.